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Abstract
Embryonic stem (ES) cell pluripotency is regulated in part by transcription factor (TF) pathways that maintain self-renewal
and inhibit differentiation. Stat3 and c-Myc TFs are essential for maintaining mouse ES cell self-renewal. c-Myc, together with
Oct4, Sox2, and Klf4, is a reprogramming factor. While previous studies have investigated core transcriptional circuitry in ES
cells, other TF pathways that promote ES cell pluripotency have yet to be investigated. Therefore, to further understand ES
cell transcriptional networks, we used genome-wide chromatin immunoprecipitation and microarray analysis (ChIP-chip) to
map Stat3 and c-Myc binding targets in ES cells. Our results show that Stat3 and c-Myc occupy a significant number of
genes whose expression is highly enriched in ES cells. By comparing Stat3 and c-Myc target genes with gene expression
data from undifferentiated ES cells and embryoid bodies (EBs), we found that Stat3 binds active and inactive genes in ES
cells, while c-Myc binds predominantly active genes. Moreover, the transcriptional states of Stat3 and c-Myc targets are
correlated with co-occupancy of pluripotency-related TFs, polycomb group proteins, and active and repressive histone
modifications. We also provide evidence that Stat3 targets are differentially expressed in ES cells following removal of LIF,
where culture of ES cells in the absence of LIF resulted in downregulation of Stat3 target genes enriched in ES cells, and
upregulation of lineage specific Stat3 target genes. Altogether, we reveal transcriptional targets of two key pluripotency-
related genes in ES cells – Stat3 and c-Myc, thus providing further insight into the ES cell transcriptional network.
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Introduction
Pluripotent embryonic stem (ES) cells, derived from mammalian
preimplantation embryos, can be cultured indefinitely in vitro and
have the ability to differentiate into all somatic and germ cell
lineages [1,2]. ES cell pluripotency can be maintained in the
presence of extrinsic signals such as leukemia inhibitory factor
(LIF) in addition to fetal calf serum (FCS). LIF belongs to the
interleukin-6 family of cytokines that signals through heterodimer-
ization of receptors gp130 and LIF-R, resulting in activation of
Jak, and phosphorylation of gp130 and LIF-R [3]. Subsequent
Stat3 phosphorylation results in nuclear translocation and target
gene transcriptional activation or repression [4]. Stat3 is necessary
to maintain ES cells in a self-renewing state [5–7]. Expression of
Stat3 maintains self-renewal in the absence of LIF [7], while
disruption of Stat3 results in ES cell differentiation [5]. While these
studies demonstrate that Stat3 is essential for ES cell pluripotency,
downstream targets of LIF/Jak/Stat3 signaling have not been fully
identified.
Although LIF-signaling is sufficient to maintain ES cell
pluripotency in serum conditions, LIF is insufficient to maintain
ES cell pluripotency in serum-free conditions. Additional factors
present in serum contribute to maintenance of pluripotency.
Recently it was shown that a combination of BMP4 and LIF has
the ability to maintain ES cell self-renewal in serum-free
conditions [8]. BMP4/Smad signaling has been shown to drive
expression of inhibitor of differentiation (Id) genes, and forced
expression of Id genes in ES cells is sufficient for maintaining self-
renewal in the absence of BMP4 [8]. Moreover, canonical Wnt
signaling has been shown to promote ES cell self-renewal in a LIF-
and serum-independent mechanism, where GSK3 inhibition
activates b-catenin resulting in nuclear translocation and associ-
ation with TCF/LEF transcription factors [9]. Therefore, BMP
and Wnt signaling are important in maintaining ES cell
pluripotency. c-Myc is one target of Wnt signaling, in which c-
Myc is activated in response to b-catenin/TCF/LEF transcription
factor activity [10]. c-Myc has been shown to maintain ES cell
pluripotency in the absence of LIF [11]. It has also been suggested
that Stat3 and c-Myc share similar downstream effector genes
[11]. Moreover, pluripotency can be conferred upon mouse and
human somatic cells through overexpression of c-Myc and three
other transcription factors (Oct4, Sox2, and Klf4) [12–15].
Evaluating transcription factor pathways involved in acquiring
and maintaining a pluripotent state is critical in understanding
mechanisms that contribute to pluripotency, acquiring a plurip-
otent state, and lineage specific differentiation. Thus, identification
of Stat3 and c-Myc targets will lend further insight into
transcriptional networks that govern ES cells pluripotency.
Recently, numerous genome-wide studies have evaluated
promoter binding of core pluripotency genes Oct4, Sox2, and
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proteins [18], Tcf3 [19], and other ES cell enriched genes [20,21].
Results from these genome-wide chromatin immunoprecipitation
and microarray analysis (ChIP-chip) and sequencing (ChIP-seq)
experiments have been useful in constructing a framework of the
ES cell transcriptional network. Continued efforts to build upon
knowledge of ES cell transcriptional networks will strengthen our
understanding of ES cell pluripotency. To this end we evaluated
Stat3 and c-Myc target genes in ES cells using genome-wide ChIP-
chip analysis.
We report that Stat3 and c-Myc occupy a significant number of
genes in ES cells that function in biological processes such as gene
expression and development. Interestingly, Stat3 and c-Myc bind
many ES cell enriched genes. By comparing Stat3 and c-Myc
target genes with gene expression data from undifferentiated ES
cells and differentiated embryoid bodies (EBs), we found that Stat3
binds both active and inactive genes in ES cells, while c-Myc binds
predominantly active genes. Moreover, Stat3 and c-Myc co-
occupancy with pluripotency-related genes and regions of active
histone modifications is correlated with target gene activity, while
Stat3 co-occupancy with polycomb repressive complex proteins
(PcG), or regions with repressive bivalent histone modifications
(H3K4/27me3) is correlated with target gene inactivity in ES cells.
Our results also reveal that Stat3 targets are differentially
expressed in ES cells in the absence of LIF. These results
demonstrate an important role for Stat3 and c-Myc in regulating
pluripotency-related gene expression in ES cells.
Results
Identification of Stat3 and c-Myc promoter binding in ES
cells
To identify genome-wide promoter-binding regions of Stat3 and
c-Myc in ES cells, we used chromatin immunoprecipitation and
DNA microarray analysis (ChIP-chip). Stat3 is a downstream
component of leukemia inhibitory factor (LIF) signaling, which is
integral in maintaining ES cells in an undifferentiated state. c-Myc
promotes ES cell self-renewal in the absence of LIF [11] and is also
a reprogramming factor [12,15]. By mapping genomic regions of
Stat3 and c-Myc promoter binding we aim to evaluate the binding
patterns of these TFs and how they are connected in the ES cell
transcriptional network. ChIP-chip analysis of histone H3
acetylation was used as a marker for actively transcribed DNA
sequences. Chromatin immunoprecipitation was performed using
antibodies specific to the TFs Stat3 and c-Myc, and AcH3
(Figure 1A, see methods). ChIP-enriched DNA sequences were
amplified and hybridized to high-density DNA promoter tiling
arrays spanning regions of 28,000 murine promoter regions (see
methods). Regions of Stat3 and c-Myc genomic binding were
determined using Tilemap [22] and annotated to the nearest
transcriptional start site (TSS) (Table S1 and S2). We found 948
genes bound by Stat3 and 1459 genes bound by c-Myc. Genomic
regions of Stat3 and c-Myc binding are located near TSSs with
many located within 5kb of TSSs (Stat3 - 54%; c-Myc - 60%)
(Figure 1B–C). Stat3 has an average length of binding of 239bp
while c-Myc has an average length of binding of 339bp (Figure 1B–
C). Stat3 and c-Myc binding profiles are shown in Figure 1D. To
evaluate the consensus-binding motifs of Stat3 and c-Myc TFs we
used the Weeder algorithm [23]. Sequences from 100 binding
peaks with the greatest number of good probes were chosen from
our Stat3 and c-Myc dataset and imported into Weeder. We
obtained the known consensus binding motifs of Stat3 (59-
TTCCCGGA-39) and c-Myc (59-CACGTG-39) from our Stat3
and c-Myc dataset (Figure 1E). These consensus binding motifs are
similar to Stat3 and c-Myc binding sequences reported previously
[20,21,24,25].
Relative to c-Myc, Stat3 binds a greater percentage of promoter
and intragenic regions, and a smaller percentage of distal regions
(Figure 1F). Co-occupancy of Stat3 and c-Myc target genes was
found at 218 promoters (Figure 1G) including genes enriched in
ES cells. Stat3 and c-Myc target genes were functionally annotated
using Ingenuity Pathway Analysis (IPA). Biological processes
enriched in Stat3 targets include gene expression, organ-, tissue-,
organismal-, and embryonic-development, and cellular growth
and proliferation (Figure 1H). Biological processes enriched in c-
Myc targets include protein synthesis, cell cycle, cancer, cellular
development, and embryonic development (Figure 1I).
Stat3 and c-Myc bind ES cell enriched genes
Genome-wide analysis of promoter binding revealed that Stat3
and c-Myc occupy many pluripotency-related genes and genes
highly enriched in ES cells. Genes bound by c-Myc include Oct4,
Sox2, Mycn, Rest, Stat3, Mbd3, Jmjd3, Gdf3, Fbxo15, Klf5, Klf7,
and Klf9 (Figure 2A, Table S2). Genes bound by Stat3 include
Sall4, Mycn, Rest, Stat3, Mbd3, Jmjd3, Tdgf1, and Fbxo15
(Figure 2B, Table S1). Genes co-occupied by Stat3 and c-Myc also
expressed highly in ES cells include Mycn, Rest, Stat3, Mbd3, and
Jmjd3 (Figure 2C, Table S1 and S2). c-Myc also binds epigenetic
regulators such as Dnmt1 and Dnmt3l (Table S2). Stat3 and c-
Myc genomic targets were confirmed using Q-PCR on ChIP-
enriched DNA sequences (Figure 3). Stat3 and c-Myc ChIP-
enriched DNA fragments were consistently over-represented
relative to non-immune control ChIP DNA fragments (Figure 3).
More than 87% of Stat3 targets were enriched over 100-fold
relative to control, while 65% of c-Myc targets were enriched over
100-fold, and 20% were enriched over 10-fold relative to control
(Figure 3B,D). These data suggest that Stat3 and c-Myc occupy
many ES cell enriched genes.
Stat3 and c-Myc occupy active and inactive genes in ES
cells
Regulation of mammalian gene expression is facilitated in part
by posttranslational modifications of histones that contribute to
chromatin organization [26]. Acetylation of Histone H3 (AcH3) is
associated with actively transcribed euchromatic chromatin
regions [26]. To evaluate chromatin regions bound by Stat3 or
c-Myc containing histone H3 aceylation we performed ChIP-chip
analysis in ES cells using an antibody specific to AcH3 (see
methods). AcH3 DNA sequences were found near TSSs of genes
highly expressed in ES cells such as Oct4, Nanog, Sox2, Rest,
Rex1, Tdgf1, Mycn, Dnmt3l, Dppa2, and Gdf3 (Figure 2 and data
not shown). Alternatively, AcH3 was not associated with lineage
specific genes repressed in ES cells such as endodermal genes
(Gata4, Gata6, Sox11, and Sox17), mesodermal genes (Fabp4,
Hand1, Hand2, and Snail), ectodermal genes (Nes, Olig1, Otx2,
and Pax5), and trophectodermal genes (Cdx2 and Tead4).
To identify Stat3 and c-Myc bound genes that are actively
transcribed, we compared Stat3 and c-Myc target genes with
regions of histone H3 acetylation (AcH3). We observed regions of
AcH3 and Stat3 or c-Myc binding at many ES cell enriched genes
including Oct4, Sox2, Mycn, Rest, Mbd3, and Tdgf1 (Figure 2).
While AcH3 is associated with actively transcribed genes, to fully
understand target gene activity or inactivity it is necessary to
directly evaluate the expression of Stat3 and c-Myc targets in ES
cells.
To evaluate the expression profile of Stat3 and c-Myc target
genes in ES cells we compared Stat3 and c-Myc target genes with
transcriptome data from R1 ES cells and embryoid-body (EB)
Stat3 & Myc ChIP in ES Cells
PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e3932Figure 1. Genome-wide analysis of Stat3 and c-Myc binding in ES cells. (A) Experimental design. See methods and text for details. ChIP-chip
analysis was used to map Stat3 and c-Myc genomic binding and regions of AcH3. Genes with AcH3 marks were considered actively transcribed.
Distribution of (B) Stat3 and (C) c-Myc binding regions relative to the nearest transcription start site (TSS) of known genes. Inset graph shows length
of (B) Stat3 and (C) c-Myc enriched DNA sequences. Y-axis represents frequency of binding and X-axis represents length of binding (bp). (D)
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PLoS ONE | www.plosone.org 3 December 2008 | Volume 3 | Issue 12 | e3932Clustering performed on Stat3 and c-Myc binding profiles centered on enrichment peaks [22kb, +2kb]. Average binding profiles are shown below
the heat map. (E) Stat3 and c-Myc enriched motifs identified using the de novo motif discovery algorithm Weeder. (F) Stat3 and c-Myc binding
distribution relative to genic and non-genic regions. (G) Venn diagram showing overlap of Stat3 and c-Myc bound genes. Gene ontology (GO)
functional annotation of (H) Stat3 and (I) bound genes was performed using Ingenuity Pathway Analysis (IPA). The 20 most significant biological
process GO terms are shown.
doi:10.1371/journal.pone.0003932.g001
Figure 2. Genomic maps of Stat3 and c-Myc binding at pluripotency-related gene loci. Stat3 and c-Myc genomic binding site and
acetylated histone H3 (AcH3) profiles at ES cell enriched gene loci. Representative (A) c-Myc bound genes (Oct4, Sox2), (B) Stat3 bound genes (Sall4,
Tdgf1), and Stat3 and c-Myc co-bound genes (Rest, Mycn, Mbd3, Stat3). Moving average (MA) enrichment values adjusted to log2 are shown.
Chromosome number, sequence position, and conservation are also indicated on the plot.
doi:10.1371/journal.pone.0003932.g002
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performed on differentially expressed genes (p-value less than 5%)
also bound by Stat3 or c-Myc (Figure 4A). We found about fifty-
percent of Stat3 target genes expressed at elevated levels in
undifferentiated ES cells compared with EBs (Figure 4A). On the
contrary, the majority of c-Myc target genes exhibited elevated
expression in undifferentiated ES cells compared with EBs
(Figure 4A). To further investigate the relationship between Stat3
Figure 3. Q-PCR analysis of Stat3 and c-Myc ChIP-enriched regions. (A) Representative Stat3 genomic binding sites confirmed by Q-PCR. Red
stars denote ChIP-chip enriched DNA sequences that were amplified using Q-PCR. (B) Confirmation of Stat3-ChIP enriched TF binding sites by Q-PCR.
(C) Representative c-Myc genomic binding sites confirmed by Q-PCR. Blue stars denote ChIP-chip enriched DNA sequences that were amplified using
Q-PCR. (D) Confirmation of c-Myc-ChIP enriched TF binding sites by Q-PCR. Q-PCR was performed on non-amplified Stat3-, c-Myc-, and IgG-ChIP
enriched and Input DNA. Results are shown as percent enrichment relative to Input. MA enrichment values adjusted to log2 are shown in addition to
sequence position. Stat3 and c-Myc enrichment are shown as red and blue heat maps respectively, while conservation is shown as a grayscale heat
map.
doi:10.1371/journal.pone.0003932.g003
Stat3 & Myc ChIP in ES Cells
PLoS ONE | www.plosone.org 5 December 2008 | Volume 3 | Issue 12 | e3932and c-Myc binding and RNA expression in ES cells and EBs we
generated a terrain map of Stat3 and c-Myc target gene expression
values using gCLUTO (Figure 4B) [28]. Stat3 and c-Myc
expression value matrices were clustered into 20 and 10 clusters
respectively to best represent the data set. Multidimensional
scaling (MDS) identified two main peaks within the Stat3 data set.
Stat3 bound genes that were differentially expressed between ES
cells and differentiated EBs were clustered into two main groups of
similar size, including (1) ES cell and early EB and (2) late EB
expression, demonstrating a relatively equal distribution of Stat3
target gene expression between ES cells and EBs (Figure 4B).
Conversely, MDS identified one main peak within the c-Myc data
Figure 4. Expression analysis of Stat3 and c-Myc bound genes in ES cells and EBs. (A) Expression analysis of Stat3 and c-Myc target genes
in ES cells and differentiated EBs through 14 days. Differentially expressed genes (FDR less than 5%) were compared with Stat3 and c-Myc target
genes. (B) Stat3 targets are both active and inactive in ES cells while c-Myc targets are mostly active in ES cells. Three dimensional terrain map of Stat3
and c-Myc target gene expression in ES cells and EBs generated using gCLUTO [28]. Stat3 bound targets are expressed in both undifferentiated ES
cells and EB, while more c-Myc targets are expressed higher in undifferentiated ES cells relative to EBs. Peak height is proportional to cluster internal
similarity and peak volume is proportional to the number of features within the cluster.
doi:10.1371/journal.pone.0003932.g004
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gene expression in ES cells and early EBs (Figure 4B). These
results suggest that Stat3 is associated with genes highly expressed
in undifferentiated and differentiated ES cells, while c-Myc is
predominantly associated with genes highly expressed in undiffer-
entiated ES cells.
About half of Stat3 target genes were expressed at elevated
levels in EBs relative to ES cells, with many of these genes lacking
significant c-Myc binding or AcH3 histone marks. Stat3 target
genes not bound by c-Myc and without AcH3 histone marks
include genes expressed in differentiated cells such as Gata2,
Gata3, Gata6, Lhx1, Pax5, Sox15, Sox21, and Wnt2b (Figure 5)
(Table S1). Stat3 also bound other genes inactive in ES cells
including many Hox genes such a Hoxa3, Hoxa10, Hoxa11,
Hoxb4, Hoxb6, Hoxb8, hoxb9, Hoxb13, Hoxc6, Hoxc8, Hoxc12,
Hoxc13, Hoxd9, Hoxd10, and Hoxd13 (Table S1). In addition to
binding Hox genes, Stat3 bound over 50 genes encoding
transcriptional regulators with homeodomain motifs. Many of
these genes are inactivate in ES cells, suggesting that Stat3 binding
represses transcription of developmentally regulated genes in ES
cells.
Gene regulation of Stat3 and c-Myc target genes by co-
occupancy of transcription factors and histone
modifications
Recent evidence suggests that genes co-bound by multiple
pluripotency genes are highly expressed in ES cells, while genes
bound by one or few pluripotency genes are generally inactive or
are expressed at low levels [21]. Additionally, polycomb group
(PcG) proteins have been shown to repress developmental genes in
ES cells [29], and H3K4/27me3 bivalent chromatin configura-
tions have been associated with developmentally repressed genes
[30]. To investigate if there is a relationship between the
expression state of Stat3 and c-Myc targets and co-occupancy by
pluripotency factors, polycomb group proteins, and histone
modifications, we compared Stat3 and c-Myc target genes with
Nanog [17] and Eed [29] target genes, and genes with AcH3 (this
paper) and H3K4/27me3 [30] histone marks. Stat3 targets were
co-bound by Nanog at 98 genes, while c-Myc targets were co-
bound by Nanog at 141 genes (Figure 6A; Table S3). Stat3 targets
were co-bound by Eed at 117 genes, while c-Myc targets were co-
bound by Eed at only 23 genes (Figure 6A; Table S3). Gene set
enrichment analysis (GSEA) [31] was used to evaluate the
expression profile of co-bound genes and genes with active and
repressive histone modifications in undifferentiated ES cells and
EBs [27] (Figure 6). Stat3 targets were expressed in ES cells or EBs
(Figure 6B), confirming that Stat3 binds active and inactive genes
in ES cells (as shown above). Actively transcribed Stat3 targets
were associated with AcH3 regions in ES cells (Figure 6C), or co-
occupancy with Nanog (Figure 6D), while inactive or repressed
Stat3 target genes were associated with regions of H3K4/27me3
(Figure 6E), or co-binding with Eed (Figure 6F), and to a lesser
extent Nanog (Figure 6D). We observed a slightly greater
association between Stat3/Nanog co-bound targets and elevated
ES cell gene expression compared with Stat3 target genes alone,
without filtering for Nanog co-occupancy. GSEA was also used to
evaluate the expression profile of c-Myc target genes in ES cells
and EBs. c-Myc targets were expressed predominantly in ES cells
(Figure 6G), confirming that c-Myc binds active genes in ES cells
(as shown above). c-Myc targets were associated with AcH3
regions in ES cells (Figure 6H), and co-occupied with Nanog
(Figure 6I), demonstrating that a subset of c-Myc target genes are
co-bound by Nanog.
While Stat3 and c-Myc co-occupy a significant number of target
genes (218 genes, Figure 1F) that are active in ES cells, genes
bound by Stat3 without c-Myc are both active and inactive in ES
cells. To evaluate the degree of co-occupancy between Stat3 and
c-Myc promoter binding and pluripotency-related TFs (Oct4 [17],
Sox2 [16], Nanog [17], PcG proteins [29] (Eed, Rnf2, Phc1, and
Suz12), and genes with bivalent histone modifications [30]
(H3K4/27me3), we compared our Stat3/c-Myc target genes with
published ChIP-chip and ChIP-seq studies in ES cells. Many Stat3
targets were also bound by c-Myc, Suz12, Phc1, Rnf2, Eed, and
Nanog, and contained H3K4/27me3 histone marks, while co-
occupancy with Oct4 and Sox2 was found at fewer genes
(Figure 6A,J). On the contrary, many c-Myc targets were co-
bound by Nanog, while co-occupancy with Eed, Rnf2, Phc1,
Suz12, Oct4, and Sox2, and H3K4/m27me3 histone marks was
found at fewer genes (Figure 6A,J). Altogether, these results
demonstrate that Stat3 and c-Myc promoter co-occupancy with
pluripotency-related TFs and genes with histone H3 acetylation is
associated with active target genes, while co-occupancy with
polycomb repressive TFs or repressive histone modifications is
associated with transcriptionally inactive target genes in ES cells.
Stat3 targets are differentially expressed in ES cells
following removal of LIF
Mouse ES cells can self-renew indefinitely in the presence of
interleukin-6 family member LIF. Because Stat3 is a direct target
of LIF signaling in ES cells, we examined the expression state of
Stat3 ChIP-chip target genes in ES cells cultured on iMEFs in the
presence or absence of LIF over a time-course of 13 days using Q-
RT-PCR. After 3 days of ES cell culture in the absence of LIF, we
observed downregulation of ES cell enriched genes Oct4, Nanog,
Rex1, Utf1, Bmp4, and ERas and Stat3 target genes Rest, Stat3,
Socs3, CD9, and Tdgf1 compared with ES cells cultured in the
presence of LIF (Figure 7A,E). Downregulation of these ES cell
enriched genes, including Stat3 mRNA, was sustained through
13 days of culture in the absence of LIF. We also observed
upregulation of genes indicative of differentiation, also bound by
Stat3, in ES cells cultured in the absence of LIF. Genes whose
expression was upregulated in ES cells during culture in the
absence of LIF, also bound by Stat3, include genes expressed in
the three germ layers and trophectodermal cells such as Brachyury
(mesoderm), Eomes (trophectoderm), Foxa2 (endoderm), Gata3
(ectoderm), Gata4 (endoderm), and Lhx1 (mesoderm)
(Figure 7C,E). These results suggest that Stat3 targets are
differentially expressed in the absence of LIF signaling. Because
some LIF is produced endogenously by iMEFs, we evaluated the
expression of a subset of Stat3 ChIP-chip targets in serum-free,
feeder-free, and LIF-independent conditions over a time-course of
5 days using Q-RT-PCR. After 3 days of ES cells cultured in
feeder-free and LIF-independent conditions, we observed down-
regulation of ES cell enriched genes Nanog, Gdf3, and Rex1 and
Stat3 target genes Rest, Stat3, Socs3, CD9, and Tdgf1 compared
with ES cells cultured in feeder-free and LIF-dependent conditions
(Figure 7B,F). We also observed upregulation of differentiation-
related genes also bound by Stat3 including Brachyury, Eomes,
Foxa2, Gata6, and Lhx1 in ES cells cultured in feeder-free and
LIF-independent conditions (Figure 7D,F). These results further
confirm that Stat3 targets are differentially expressed in the
absence of LIF.
Discussion
Mouse ES cells have the ability to self-renew indefinitely in the
presence of LIF. Although it is known that LIF signaling through
Stat3 & Myc ChIP in ES Cells
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transcriptional targets of Stat3 have not been fully identified.
However, it has been suggested that Stat3 and c-Myc share
downstream targets. c-Myc can maintain ES cell self-renewal
independent of LIF signaling [11], and c-Myc is also one of several
proteins, along with Oct4, Sox2, and Klf4, that when co-expressed
in mouse and human somatic cells, facilitates nuclear reprogram-
ming to a pluripotent state [12–15]. Because Stat3 and c-Myc are
necessary for establishing and maintaining a pluripotent state,
evaluation of Stat3 and c-Myc downstream transcriptional targets
provides further insight into the ES cell transcriptional network.
Therefore, we used genome-wide chromatin immunoprecipitation
and microarray analysis (ChIP-chip) to map Stat3 and c-Myc
promoter binding sites in mouse ES cells. Here, we demonstrate
that Stat3 and c-Myc occupy many ES cell enriched genes.
Additionally, by evaluating Stat3 and c-Myc ChIP-chip target
gene expression profiles in undifferentiated ES cells and
differentiated EBs, we observed Stat3 binding to both active and
inactive genes, while c-Myc was bound to mainly active genes in
ES cells (Figure 8). Furthermore, we found that co-occupancy of
Stat3 and c-Myc target genes with pluripotency-related TFs and
regions of active histone modificiations is correlated with gene
activity, while Stat3 co-occupancy with polycomb repressive
proteins and regions of repressive histone modifications is
correlated with gene inactivity (Figure 8A–C). We also observed
activation or repression of Stat3 target genes in the absence of LIF
signaling, concomitantly with reduced Stat3 transcript levels,
suggesting that Stat3 promoter occupancy plays a role in
regulating target gene expression.
Our results showing that Stat3 associates with both active and
inactive genes in ES cells, while c-Myc associates with predom-
inantly active genes, is consistent with previous reports demon-
strating that Stat3 and c-Myc promote and inhibit transcription by
associating with co-activators and co-repressors. Stat3 association
with co-activators steroid receptor coactivator 1 (NcoA/SRC1a)
and cAMP response element binding protein/p300 (CBP/p300)
augment Stat3 transcriptional activity [32]. Crif1 has also been
shown to be a coactivator of Stat3 [33]. Stat3 can also associate
with co-repressor Kap1/Tif1b to inhibit transcription [34–36],
where Kap1 inhibits transcription by recruiting histone deacety-
Figure 5. Stat3 binds developmentally repressed genes in ES cells. Genome-wide analysis of Stat3 and c-Myc TF binding sites and histone H3
acetylation (AcH3) at developmentally repressed genes (Gata6, Gata3, Pax5, Sox21, and Lhx1). Moving average (MA) enrichment values adjusted to
log2 are shown. Chromosome number, sequence position, and conservation are also indicated on the plot.
doi:10.1371/journal.pone.0003932.g005
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ase [37–39]. c-Myc, like Stat3, is known to associate with both co-
activators and co-repressors. c-Myc can associate with co-repressor
proteins Kap1/Tif1b and Hdac to negatively regulate transcrip-
tion of target genes [38]. While we observed c-Myc binding to
mainly active genes in ES cells, c-Myc was bound to a minimal set
of inactive genes. These data suggest that Stat3 activates and
represses target gene transcription in ES cells, while c-Myc mainly
activates genes.
Further analysis of our ChIP-chip data showed that c-Myc
occupied 135 genes encoding proteins of ribonucleotide protein
complexes, and 82 genes encoding structural constituents of
ribosomes. The most significant biological process overrepresented
in c-Myc targets included genes involved in protein synthesis
(Figure 1H). c-Myc has been shown to function in regulating gene
expression of ribosomsal proteins/RNAs [40,41]. Moreover, c-
Myc induced tumorigenesis is correlated with ribosomal protein
expression [42], suggesting that c-Myc induced expression of
ribosomal proteins is involved in tumorigenesis. By occupying and
regulating transcription of ribosomal proteins, c-Myc may
promote the tumorigenic growth property of ES cells.
Pluripotency can be induced in somatic cells through cell fusion
with ES cells [43], where Nanog enhances the efficiency of cell-
fusion induced reprogramming [44]. Additionally, overexpression
of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) is
sufficient to reprogram mouse embryonic fibroblasts (MEFs) [12]
and human fibroblasts [13–15] to a pluripotent state (iPS cells).
Our data shows that c-Myc binds three out of the four
reprogramming factors (Oct4, Sox2, Mycn) and one other another
gene, Klf5, which is functionally redundant to the reprogramming
factor Klf4 [18]. While c-Myc has been shown to be dispensable
for inducing pluripotency [45], the frequency of generating iPS
cells is lower without Myc. c-Myc may enhance reprogramming
by augmenting transcription of pluripotency inducing factors
through direct promoter binding.
c-Myc has also been shown to be involved in other cellular
processes such as cell cycle progression [46]. In our ChIP-chip
dataset we found c-Myc promoter occupancy at many cell cycle
regulatory genes including cyclin genes such as Ccnb1, Ccnd1,
Ccne1, Ccnf, Ccng1, and Ccnt2; cyclin dependent kinase genes
such as Cdk4, Cdk6, Cdk7, and Cdkl3; and other cell cycle
regulatory genes including Cdc26, Cdc6, Cdca1, Cdca7, Cdca8,
and Cdk2ap1 (Table S2). Further functional annotation of c-Myc
targets using IPA identified many additional cell cycle regulatory
genes bound by c-Myc such as Bard1, Bax, Ctcf, Daxx, Dnmt1,
Hes1, Max, Mycn, Rb1, and Sox2. c-Myc promoter occupancy of
cell cycle regulatory genes may play a role in the rapid cell division
of ES cells (,12 hrs).
In summary, genomic maps of Stat3 and c-Myc promoter
binding in ES cells reveal previously unknown targets of two key
genes necessary for ES cell pluripotency. Identifying targets of
Stat3 and c-Myc strengthens our understanding of the ES cell
transcription network. ChIP-chip studies utilizing promoter-tiling
arrays are powerful in identifying protein/DNA interactions near
TSSs of known genes in ES cells. However, to identify TF binding
near distal enhancers or unknown genes it will be necessary to
perform additional analyses such as whole-genome tiling array
analysis (ChIP-chip) or sequential ChIP (ChIP-seq). Further
investigation of ES cell TF networks will reveal how mechanisms
of gene expression contribute to pluripotency, reprogramming,
and lineage specific differentiation.
Materials and Methods
ES cell culture
R1 ES cells, cultured as previously described [47], were
obtained from ATCC (Manassas, VA), and maintained at 37uC
with 5% CO2 on irradiated mouse embryonic fibroblasts (iMEFs)
in high-glucose containing DMEM (Gibco-BRL), 15% ES cell
qualified FCS (Hyclone, Logan, UT), 1,000 units/mL LIF
(Cellgro), penicillin/streptomycin, L-glutamine, non-essential ami-
no acids, and 50 mM b-mercaptoethanol (Gibco-BRL). Feeder-
free ES cells were cultured in gelatin-coated dishes and
transitioned into serum-free media (ESGRO Complete, Chemi-
con). R1 ES cells were cultured at 37uC with 5% CO2 in gelatin-
coated dishes in serum-free media (ESGRO complete clonal grade
medium, Chemicon), passaged by washing with PBS, and
dissociated with accutase (Chemicon).
RNA isolation and Q-RT-PCR of ES cells grown with and
without LIF
RNA isolation and Q-RT-PCR were performed as previously
described with minor modifications [48]. ES cells were harvested
using 0.25% trypsin (Invitrogen) to dissociate cells, centrifuged in
10% FCS DMEM medium to inactivate trypsin, and pelleted. To
remove feeder cells, ES cells were plated in gelatin-coated dishes in
ES cell media without iMEFs, and incubated at 37uC with 5%
CO2 for 20–30 minutes. After 20–30 minutes, the medium was
aspirated gently and cells were pelleted. Total RNA was extracted
from ES cells cultured with or without LIF using an RNeasy Mini
Kit (Qiagen, Valencia, CA) and DNase treated using Turbo DNA-
free (Ambion) for 30 minutes at 37uC. Reverse transcription was
performed using a Superscript III kit with random hexamer
primers (Invitrogen, Carlsbad, CA). Q-RT-PCR was performed
using TaqMan assays with TaqMan Universal PCR Master Mix
reagents or SYBR Green PCR Master Mix reagents (Applied
Biosystems).
Chromatin immunoprecipitation and DNA microarray
analysis (ChIP-chip)
The polyclonal Stat3 antibody (C-20, SC-482) and the
polyclonal c-Myc antibody (N-262, SC-764) were obtained from
Santa Cruz Biotechnology. The polyclonal AcH3 (acetyl-histone-
H3, #06-599) and rabbit IgG (PP64B) antibody were obtained
from Upstate. 1610
8 mouse R1 ES cells (feeder-free) were
harvested and chemically crosslinked with 1% formaldehyde
(Sigma) for 20 hours at 4uC. Fixation was quenched by addition of
1/20 volume 2.5 M glycine for 5 minutes at room temperature.
Cells were pelleted at 4uC (500 g), washed with ice-cold 16PBS,
washed twice with lysis buffer (10 mM Tris-HCL, 10 mM NaCl,
3 mM MgCl2, 0.5% GEPAL, 1 mM fresh PMSF), pelleted, and
Figure 6. Association between TF co-occupancy and expression profile in ES cells and EBs. (A) Relationship between Stat3 and c-Myc
bound genes with Nanog, Oct4, Eed, and Suz12 bound genes. GSEA analysis of (B) Stat3 target genes, (C) Stat3 target genes with AcH3 marks, (D)
Stat3/Nanog target genes, (E) Stat3 target genes with H3K4/27me3 marks, and (F) Stat3/Eed target genes in ES cells and differentiated EBs. GSEA
analysis of (G) c-Myc target genes, (H) c-Myc target genes with AcH3 marks, and (I) c-Myc/Nanog target genes in ES cells and differentiated EBs. Red
indicates active genes in ES cells and blue indicates active genes in EBs. (J) Relationship between Stat3 and c-Myc target genes, Oct4/Sox2/Nanog
target genes, polycomb repressive complex 1 (Rnf2/Phc1), polycomb repressive complex 2 (Suz12/Eed), and genes with histone marks H3K4/27me3.
The number of genes co-bound by Stat3 or c-Myc is displayed.
doi:10.1371/journal.pone.0003932.g006
Stat3 & Myc ChIP in ES Cells
PLoS ONE | www.plosone.org 10 December 2008 | Volume 3 | Issue 12 | e3932Figure 7. Global gene expression of Stat3 and c-Myc target genes in ES cells cultured in the absence of LIF. Pluripotency-related genes
and genes bound by Stat3 and c-Myc were downregulated in ES cells cultured in the absence of LIF. (A) Q-RT-PCR expression analysis of ES cell
enriched genes and genes bound by Stat3 or c-Myc (Oct4, Nanog, ERas, Rest, Gdf3, Rex1, Stat3, Socs3, CD9, Bmp4, Utf1, and Tdgf1) in ES cells cultured
on iMEFs with and without LIF. (B) Q-RT-PCR expression analysis of ES cell enriched genes and genes bound by Stat3 or c-Myc in ES cells cultured in
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dilution buffer (10 mM Tris-HCL, 10 mM NaCl, 3 mM MgCl2,
1 mM CaCl2, 4% GEPAL, 1 mM PMSF), 60 mL PMSF, and
additional components (100 mM PMSF, 256 protease inhibitor,
20% SDS, 5 M NaCl, H2O). Cells were sonicated using a Branson
Sonifier 450D at 50% amplitude, with 1261 minutes pulses,
followed by 1 minute rests in ice water. Sonicated fragments
ranged in size from 200–1000 bp. Post sonication, samples were
centrifuged at 14,000 rpm for 10 minutes at 4uC, aliquoted, and
flash frozen in liquid nitrogen. Sonicated cell extracts equivalent to
2610
6 cells were used in subsequent immunoprecipitations.
Samples were pre-cleared with protein G Dynabeads (Dynal) in
1000 mL dilution buffer (0.01% SDS, 1.1% Triton X-100,
1.2 mM EDTA, 16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl,
5 mL Upstate protease inhibitor cocktail II). Cell extracts were
incubated with 1 mg antibody overnight at 4uC. Chromatin-
antibody complexes were isolated with 100 mL protein G
Dynabeads, and washed one time with low salt buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl,
150 mM NaCl), one time with high salt buffer (same as low salt
with 500 mM NaCl), one time with LiCl wash buffer (0.25 M
LiCl, 1% IGEPAL-CA630, 1% deoxycholic acid, 1 mM EDTA,
10 mM Tris), and twice with TE. Protein/DNA complexes were
eluted from the beads in 10 mL 20% SDS, 20 mL 1 M NaHCO3,
and 170 mLH 2Oa t6 5 uC with occasional vortexing. Crosslinking
was reversed by addition of 8 mL 5 M NaCl and incubation
overnight at 65uC. Extracts were then treated with RNase A and
proteinase K, and DNA was purified using an Upstate EZ ChIP
kit. 5 mg purified DNA (Stat3-chip, c-Myc-chip, AcH3-chip, and
Input) was amplified using a GenomePlexH Whole Genome
Amplification (WGA) Kit (Sigma), DNase treated, and labeled
with a GeneChipH WT Double-Stranded DNA Terminal
Labeling Kit. Labeled DNA was hybridized to Affymetrix mouse
promoter 1.0R tiling arrays for 16 hours at 45uC in an Affymetrix
GeneChipH Hybridization Oven 640, washed using a GeneChipH
Fluidics Station 450, and scanned with a GeneChipH Scanner 7G
at EMD SRI. Immunoprecipitated (Stat3, c-Myc, and AcH3) and
non-immune (rIgG) control sample biological triplicates were used
for ChIP-chip analysis. Mouse promoter 1.0R DNA tiling arrays
contain 4.6 million 25-mer oligonucleotide probes covering a
distance of -6kb to +2.5kb relative to the transcriptional start site
for 28,000 mouse promoter regions annotated from ENSEMBL
feeder-free, serum-free, and LIF-containing and LIF-independent conditions. Genes indicative of differentiation were upregulated in ES cells cultured
in the absence of LIF. (C) Q-RT-PCR expression analysis of lineage specific genes bound by Stat3 (Brachyury, Eomes, Foxa2, Gata3, Gata6, and Lhx1) in
ES cells cultured with and without LIF. (D) Q-RT-PCR expression analysis of lineage specific genes bound by Stat3 (Brachyury, Eomes, Foxa2, Gata6,
and Lhx1) in ES cells cultured in feeder-free, serum-free, and LIF-containing and LIF-independent conditions. Data was normalized to Gapdh as an
internal control and then to the expression level of ES cells cultured in the presence of LIF at 3 days. Heat map summary of global gene expression in
(E) ES cells cultured in the presence or absence of LIF through 13 days and (F) ES cells cultured in feeder-free, serum-free, and LIF-containing and LIF-
independent conditions for 5 days. Fold-change expression values were clustered using Spotfire.
doi:10.1371/journal.pone.0003932.g007
Figure 8. Interaction of Stat3 and c-Myc transcription factors with promoters of ES cell enriched and lineage specific genes.
Transcriptional regulation of c-Myc and Stat3 target genes in ES cells. (A) Actively transcribed c-Myc and Stat3 targets are associated with regions of
AcH3. c-Myc occupies a greater number of active genes than Stat3; Stat3 and c-Myc co-occupy a number of ES cell enriched genes. The red triangle
represents highly expressed genes in ES cells. (B) Inactive genes occupied by Stat3 and c-Myc are bound by polycomb group proteins and are
associated with regions of repressive histone modifications. The gray triangle labeled [R] represents repressive proteins and histone modifications.
Stat3 occupies a greater number of inactive genes in ES cells relative to c-Myc. The green triangle represents inactivate genes in ES cells. (C)
Transcriptional regulatory circuit of Stat3 and c-Myc bound genes.
doi:10.1371/journal.pone.0003932.g008
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mRNAs (NCBI GenBankH). These tiling arrays provide a
resolution of 35 bp with 10 bp gaps between probes.
Peak detection and gene annotation
Quantile normalization, including probe intensity computation
and log2 adjustment was applied to Affymetrix tiling array data
(Stat3, c-Myc, and Input) using CisGenome (http://www.biostat.
jhsph.edu/,hji/cisgenome/). Peak detection was done using the
TileMap [22] (http://biogibbs.stanford.edu/,jihk/TileMap/in-
dex.htm) application in CisGenome. MA statistics was applied to
analyze the tiling array data [22]. Post filtering included discarding
peaks if the total length was less than 100 bp or there were less
than 3 continuous probes passing the cutoff. Peak post filtering also
included merging two adjacent peaks if the gap between the two
peaks was less than 300 bp and the there were less than 5 probes
that did not pass the cutoff between the two peaks. FDR statistics
(left tail) were also estimated. TileMap utilizes a two-step approach
for analyzing DNA binding regions. First, a hierarchical empirical
Bayes model is used to compute a test-statistic for each probe [22].
Second, probe test-statistics in a genomic region are used to
determine significance of hybridization. Enrichment peaks were
annotated with the closest gene and defined by the distance
upstream to the TSS and the distance downstream of the TES.
Build 36 of the mouse genome was used in these analyses.
Confirmation of ChIP-chip binding regions using Q-PCR
Primers were designed for Stat3 and c-Myc ES cell ChIP-
enriched genomic DNA regions using Primer 3 (http://frodo.wi.
mit.edu/). Real-time Q-PCR was performed on non-amplified
Stat3, c-Myc, rabbit IgG, and Input ES cell ChIP DNA using
SYBR Green Master Mix reagents with an ABI PRISM 7900HT
sequence detection system.
Microarray analysis
Annotated Stat3 and c-Myc ChIP-chip regions were compared
with a published microarray dataset to evaluate developmental
expression patterns of Stat3 and c-Myc bound genes. Affymetrix
expression data from ES cells and embryoid bodies (EB)
(GSE2972) [27] was download from Gene Expression Omni
(GEO). CEL files were imported into ArrayAssist (Stratagene, Lo
Jolla, CA) and probe levels were normalized using the GeneChipH
Robust Multiarray Average (GCRMA) algorithm. Analysis of
variance (ANOVA) was performed on all groups using a
Benjamini and Hochberg false-discovery rate (FDR) correction.
Hierarchical clustering analysis was performed on log-transformed
statistically significant (P-value less than 5%) mean-centered data
using Spotfire (Cambridge, MA).
Supplemental Data
Supplemental data include three tables.
Supporting Information
Table S1 Stat3 bound regions in murine ES cells
Found at: doi:10.1371/journal.pone.0003932.s001 (0.11 MB
XLS)
Table S2 c-Myc bound regions in murine ES cells
Found at: doi:10.1371/journal.pone.0003932.s002 (0.17 MB
XLS)
Table S3 Stat3 and c-Myc occupied genes co-bound with Oct4
and Nanog
Found at: doi:10.1371/journal.pone.0003932.s003 (0.15 MB
XLS)
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